GCT 2013 Post Event Report

Shri Parbatbhai Patel, Hon’ble Health Minister (State) Gujarat said, this year Gujarat Medical Services Corporation Limited (GMSCL) has raised procurement budget of Rs. 200 crore from last year budget of Rs. 150 cr which will greatly benefit the Gujarat based generic drugs makers.

GCT 2013

GENERIC DRUG, CLINICAL TRIALS & CLOUD TECHNOLOGY
April 30th 2013 at Hotel Metropole, Ahmedabad

Viewing huge opportunity for pharmaceutical companies to sell their products in emerging markets due to rising incomes, higher incidence of chronic and lifestyle diseases, better insurance coverage and better patent protection regimes for drugs, major roadblocks such as lack of mature distribution networks, lower price points due to generics competition, and counterfeiting are leaving even the large companies struggling to handle the challenges from some of these less sophisticated markets. ASSOCHAM in its quest to resolve these issues and create a fine link through global regulators and industry experts moreover to bring first hand information at the disposal has organised “GCT 2013, Challenges & Opportunities”.

@GTC 2013

1. Shri Jay Ruparel, Co-chaierson, ASSOCHAM Gujarat Council
2. Shri Parbatbhai Patel, Hon’ble Minister (S), Health and Family Welfare, Gujarat
3. Ms. Bhagyesh Soneji, Chairperson, ASSOCHAM Gujarat Council
4. Shri Kamlesh Patel, Former Chairman, IDMA.

While inaugurating the ASSOCHAM conference on “Generic Drug, Clinical Trials & Technology” Shri Parbatbhai Patel, Hon’ble Health Minister (State) Gujarat said, this year Gujarat Medical Services Corporation Limited (GMSCL) has raised procurement budget of Rs. 200 crore from last year budget of Rs. 150 cr which will greatly benefit the Gujarat based generic drugs makers.

He further added that nearly 52,000 people are employed in Gujarat’s pharmaceutical sector, which has witnessed 54% compound annual growth rate (CAGR) in capital investments over the last three years. There are currently 3,500 drug manufacturing units in Gujarat.

Ms. Bhagyesh Soneji, Chairperson, ASSOCHAM Gujarat Council said, “Gujarat’s pharma industry is good example of a well-developed ecosystem with strong building blocks that have helped the industry grow at such a phenomenal pace like proactive government policies and an investor friendly regime is one of the main building blocks for the growth of the pharmaceutical as well as any other industry. The other reasons include modern and well-developed infrastructure, Gujarat boasts one of the best infrastructure facilities in the country be it roads, ports, power or other logistical facilities, Gujarat ranks much higher than other competing states.

A White Paper jointly Prepared by Apheta Institute of Clinical Research and ASSOCHAM on GCT 2013 has also been released during the conference by Hon’ble Minister which explain some data for pharma and healthcare industry as under:

  • Current clinical research industries of Rs 8,000 crore may touch $1.5bn ($1500m) and generate 50,000 professionals employment in the next five years.
  • Market value for clinical trials outsourced to India is estimated at around $300 million, increased by 65% in 2006, it is expected to touch $1.5-2.5 billion by 2014.
  • By 2014, the industry will spend USD 450M on clinical trials in India
  • Between 5 -10% of the global contract research outsourced market (all services including chemistry, toxicology and clinical research) over next 5 years.
  • Market value for clinical trials outsourced to India is estimated at around $300 million, having increased by 65% in 2006, it is expected to touch $1.5-2.5 billion by 2014. By 2014, the industry will spend USD 450 M on clinical trials in India.
  • The value of the global pharmaceutical market expected to grow by 7–8% in 2014 to US$ 900 billion, compared with a 4–5% pace in 2010.
  • The Indian pharmaceutical industry is growing at an annual rate of 11 % while the clinical research industry is growing at an annual rate of 84%.

List of Speakers:

  • Ms. Bhagyesh Soneji, Chairperson, ASSOCHAM Gujarat Council and CMD, AMEDA Pharma Pvt. Ltd.
  • Shri Kamlesh Patel, Ex-Chairman, Indian Drug Manufacturer Association (IDMA) and CEO, West-Coast Pharmaceutical Works Ltd.
  • Shri Parbatbhai S. Patel, Hon’ble Health Minister(S) of Gujarat
  • Shri Jay Ruparel, Co-Chairperson, ASSOCHAM Gujarat Council and CEO, Azure Knowledge Corporation
  • Dr. Sadhna Shrivastava, Scientiest, Indian Council  of Medical Research, Ministry of Health and Family Welfare, GoI
  • Mr. Siddarth Dhodi (Life Sciences Knowledge Banking – YES BANK)
  • Dr. Unnat Pandit, Expert Technology Transfer, IPR , Cadila Pharmaceuticals Ltd
  • Dr. Bhagirath Patel, Director, Shivrath Centre of Excellence in Clinical Research, A Joint Venture with Gujarat State Biotechnology Mission, Government of Gujarat
  • Shri Paresh Mistry, Sr. General Manager-QA (BA\BE & CT), Accutest India